Titan Pharma (TTNP) to Sell Up to $20M in Common Stock Through Cantor
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Titan Pharma (NASDAQ: TTNP) entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co., as agent, pursuant to which the Company may offer and sell, from time to time through Cantor, shares of the Company’s common stock, par value $0.001 per share, having an aggregate offering price of up to $20.0 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Theravance Biopharma (TBPH) Announces $100M Shares, $150M Conv. Stock Offerings
- Red Rock Resorts (RRR) Files 37.5M Share Common Stock Shelf for Selling Shareholder
- Collegium Pharma (COLL) Announces Common Stock Offering
Create E-mail Alert Related CategoriesEquity Offerings
Related EntitiesCantor Fitzgerald
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!